Journal article
Establishment of normal myofiber size distribution in children and young adults
Journal of neuropathology and experimental neurology, Vol.84(12), pp.1159-1173
12/01/2025
DOI: 10.1093/jnen/nlaf123
PMCID: PMC12713552
PMID: 41206585
Abstract
Abnormalities of myofiber size are often of diagnostic significance on skeletal muscle biopsies, mainly when myofibers are excessively small. The establishment of standards for myofiber size in children has been hampered until recently by the lack of tools to assess large numbers of fibers across a sizeable number of samples. This study describes the assessment of myofiber size in 349 histologically normal patient biopsy specimens obtained between 4 weeks and 25 years of life and corresponding primarily to locations in the thigh/quadriceps/vastus lateralis region. Biopsy specimens were selected for inclusion based on histologically normal light microscopic findings and minimal technical artifacts. H&E-stained slides were scanned and evaluated for minFeret diameter using a Visiopharm software app (APP #10164). MinFeret diameter fiber size data were then grouped into 18 age cohorts to establish normal ranges for males and females within each age cohort. A pilot study to compare known abnormal cases to these normal ranges was then performed to demonstrate how cases with abnormal fiber size might compare to these standards. This dataset provides a user-friendly and applicable set of standard fiber size ranges to assist in diagnostic and scientific work in children and young adults.
Details
- Title: Subtitle
- Establishment of normal myofiber size distribution in children and young adults
- Creators
- Michael W Lawlor - Medical College of WisconsinMarta Margeta - University of California, San FranciscoKarra A Jones - Duke UniversityBenedikt Schoser - Ludwig-Maximilians-Universität MünchenJennifer A Cotter - Children's Hospital of Los AngelesVeena Rajaram - The University of Texas Southwestern Medical CenterSteven A Moore - University of IowaMariah J Prom - Diverge Translational Science Laboratory, Milwaukee, WI, United StatesMargaret Beatka - Diverge Translational Science Laboratory, Milwaukee, WI, United StatesEmily Ott - Diverge Translational Science Laboratory, Milwaukee, WI, United StatesRebecca A Slick - Medical College of WisconsinMichael P Collins - Medical College of WisconsinAnn Esselman - Medical College of WisconsinNazima Shahnoor - Medical College of WisconsinSusan Danielson - Medical College of WisconsinHui Meng - Diverge Translational Science Laboratory, Milwaukee, WI, United StatesFatbardha Varfaj - Formerly of Astellas Gene Therapies (formerly Audentes Therapeutics), San Francisco, CA, United StatesSuyash Prasad - Formerly of Astellas Gene Therapies (formerly Audentes Therapeutics), San Francisco, CA, United StatesSalvador Rico - Formerly of Astellas Gene Therapies (formerly Audentes Therapeutics), San Francisco, CA, United StatesJun Lee - Formerly of Astellas Gene Therapies (formerly Audentes Therapeutics), San Francisco, CA, United StatesSuresh N Kumar - Medical College of WisconsinHeather Gordish Dressman - George Washington University
- Resource Type
- Journal article
- Publication Details
- Journal of neuropathology and experimental neurology, Vol.84(12), pp.1159-1173
- DOI
- 10.1093/jnen/nlaf123
- PMID
- 41206585
- PMCID
- PMC12713552
- NLM abbreviation
- J Neuropathol Exp Neurol
- ISSN
- 0022-3069
- eISSN
- 1554-6578
- Publisher
- Oxford University Press
- Grant note
- Astellas Gene Therapies
- Language
- English
- Electronic publication date
- 11/04/2025
- Date published
- 12/01/2025
- Academic Unit
- Pathology
- Record Identifier
- 9985027354602771
Metrics
11 Record Views